![](/img/cover-not-exists.png)
Poly (ADP-ribose) polymerase (PARP) inhibitors for the treatment of advanced germline BRCA2 mutant prostate cancer
Sandhu, S. K., Omlin, A., Hylands, L., Miranda, S., Barber, L. J., Riisnaes, R., Reid, A. H., Attard, G., Chen, L., Kozarewa, I., Gevensleben, H., Campbell, J., Fenwick, K., Assiotis, I., Olmos, D., YVolume:
24
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdt074
Date:
May, 2013
File:
PDF, 58 KB
english, 2013